JP2023526584A - Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物 - Google Patents

Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物 Download PDF

Info

Publication number
JP2023526584A
JP2023526584A JP2022564201A JP2022564201A JP2023526584A JP 2023526584 A JP2023526584 A JP 2023526584A JP 2022564201 A JP2022564201 A JP 2022564201A JP 2022564201 A JP2022564201 A JP 2022564201A JP 2023526584 A JP2023526584 A JP 2023526584A
Authority
JP
Japan
Prior art keywords
nitric oxide
nitrite
organic
composition
sars
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022564201A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526584A5 (enExample
Inventor
センプル ムンロー ヒュー
バリー ウッド クリストファー
デイヴィッド ブート ニコラス
ポール クリス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thirty Respiratory Ltd
Original Assignee
Thirty Respiratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2005987.9A external-priority patent/GB202005987D0/en
Priority claimed from GBGB2008288.9A external-priority patent/GB202008288D0/en
Application filed by Thirty Respiratory Ltd filed Critical Thirty Respiratory Ltd
Publication of JP2023526584A publication Critical patent/JP2023526584A/ja
Publication of JP2023526584A5 publication Critical patent/JP2023526584A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2022564201A 2020-04-23 2021-04-19 Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物 Pending JP2023526584A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2005987.9A GB202005987D0 (en) 2020-04-23 2020-04-23 Methods and compositions for treating and combatting sars-cov and sars-cov-2
GB2005987.9 2020-04-23
GB2008288.9 2020-06-02
GBGB2008288.9A GB202008288D0 (en) 2020-06-02 2020-06-02 Methods and compositions for treating and combatting sars-cov and sars-cov-2
PCT/GB2021/050935 WO2021214440A1 (en) 2020-04-23 2021-04-19 Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2

Publications (2)

Publication Number Publication Date
JP2023526584A true JP2023526584A (ja) 2023-06-22
JP2023526584A5 JP2023526584A5 (enExample) 2024-04-18

Family

ID=75746956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022564201A Pending JP2023526584A (ja) 2020-04-23 2021-04-19 Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物

Country Status (9)

Country Link
US (1) US20240016831A1 (enExample)
EP (1) EP4138795A1 (enExample)
JP (1) JP2023526584A (enExample)
CN (1) CN115884758A (enExample)
AU (1) AU2021259360A1 (enExample)
BR (1) BR112022021454A2 (enExample)
CA (1) CA3180857A1 (enExample)
GB (1) GB2610722B (enExample)
WO (1) WO2021214440A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
WO2023118839A1 (en) * 2021-12-22 2023-06-29 Thirty Holdings Limited Powder composition
AU2022422475A1 (en) * 2021-12-22 2024-07-04 Convatec Limited Powder composition
GB202215521D0 (en) * 2022-10-20 2022-12-07 Thirty Holdings Ltd Wound dressings
GB202302118D0 (en) * 2023-02-14 2023-03-29 Thirty Therapeutics Ltd Compositions, kits and combinations
GB202302117D0 (en) * 2023-02-14 2023-03-29 Thirty Respiratory Ltd Compositions, kits and combinations
US20260090985A1 (en) * 2024-10-02 2026-04-02 Aspire Biopharma Holdings, Inc. Oral mucosal formulations of aspirin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP2002538210A (ja) * 1999-03-09 2002-11-12 クイーン メアリー アンド ウェストフィールド カレッジ 皮膚虚血症を治療するための硝酸塩源及び酸性化剤を含む医薬組成物
JP2004508337A (ja) * 2000-09-08 2004-03-18 アバディーン　ユニヴァーシティ 薬剤耐性生物の治療
JP2005508957A (ja) * 2001-10-19 2005-04-07 バーツ　アンド　ザ　ロンドン　エヌエイチエス　トラスト 治療用組成物および用途
JP2009533396A (ja) * 2006-04-12 2009-09-17 バーツ アンド ザ ロンドン エヌエイチエス トラスト 治療用組成物及びその使用

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826255A (en) 1972-06-22 1974-07-30 Hudson Oxygen Therapy Sales Co Intermittent positive pressure breathing manifold
YU41046B (en) 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
US4130639A (en) 1977-09-28 1978-12-19 Ethicon, Inc. Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4253468A (en) 1978-08-14 1981-03-03 Steven Lehmbeck Nebulizer attachment
US4263907A (en) 1979-05-14 1981-04-28 Lindsey Joseph W Respirator nebulizer
US4510929A (en) 1982-04-30 1985-04-16 Bordoni Maurice E Disposable radioactive aerosol inhalation apparatus
US4649911A (en) 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
NZ241579A (en) 1991-03-25 1994-04-27 Becton Dickinson Co Antimicrobial formulations for treating the skin
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
ATE155695T1 (de) 1991-11-07 1997-08-15 Ritzau Pari Werk Gmbh Paul Vernebler insbesondere zur anwendung in geräten für die inhalationstherapie
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5709202A (en) 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
WO1995009605A1 (en) 1993-10-06 1995-04-13 Henkel Corporation Improving phenolic disinfectant cleaning compositions with alkylpolyglucoside surfactants
US6034133A (en) 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
PL180769B1 (pl) 1994-02-21 2001-04-30 Univ Aberdeen Postać dawkowana do miejscowego leczenia stanów powodowanych przez drobnoustroje, sposób sterylizacji obiektów i kompozycja sterylizująca
GB9804469D0 (en) 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US5681802A (en) 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
US5635462A (en) 1994-07-08 1997-06-03 Gojo Industries, Inc. Antimicrobial cleansing compositions
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
US5702754A (en) 1995-02-22 1997-12-30 Meadox Medicals, Inc. Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
WO1996025918A1 (en) 1995-02-24 1996-08-29 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
ZA962455B (en) 1995-03-31 1996-10-02 B Eugene Guthery Fast acting and persistent topical antiseptic
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
US5955408A (en) 1996-07-10 1999-09-21 Steris Inc. Triclosan skin wash with enhanced efficacy
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6258368B1 (en) 1997-06-04 2001-07-10 The Procter & Gamble Company Antimicrobial wipes
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
CA2301569A1 (en) 1997-10-08 1999-04-15 Martin P. Redmon Dosage form for aerosol administration
DK1129741T3 (da) 1997-11-19 2006-08-07 Microflow Eng Sa Forstövningsindretning til inhalator
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
US6258371B1 (en) 1998-04-03 2001-07-10 Medtronic Inc Method for making biocompatible medical article
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
EP1100556B1 (en) 1998-07-31 2003-11-12 First Water Limited Bioadhesive compositions and biomedical electrodes containing them
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers
US6070575A (en) 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
JP2000355667A (ja) 1999-04-14 2000-12-26 Seiko Epson Corp カラーインクジェット記録用水系顔料インクセット、カラーインクジェット記録方法、及びカラーインクジェット記録物
US6338443B1 (en) 1999-06-18 2002-01-15 Mercury Enterprises, Inc. High efficiency medical nebulizer
US6107261A (en) 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
WO2001076671A2 (en) 2000-04-11 2001-10-18 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
US6601581B1 (en) 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
GB0119011D0 (en) 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
US7066356B2 (en) 2002-08-15 2006-06-27 Ecolab Inc. Foam soap dispenser for push operation
WO2005081752A2 (en) 2004-02-09 2005-09-09 Amulet Pharmaceuticals, Inc. Nitric oxide-releasing polymers
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2007007115A2 (en) 2005-07-14 2007-01-18 First Water Limited Treatment of chronic ulcerous skin lesions
CN101028229B (zh) 2006-03-02 2012-09-05 北京富丽华德生物医药科技有限公司 基于一氧化氮的新型化妆品
CN101062050A (zh) 2006-04-29 2007-10-31 北京尼奥克斯生物科技有限公司 一种基于一氧化氮的新型生发产品及其制备方法
EP2040542A2 (en) 2006-05-30 2009-04-01 The Dial Corporation Compositions having a high antiviral effeicacy
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
GB0700908D0 (en) 2007-01-17 2007-02-28 First Water Ltd Inhibition of proteases, particularly in the treatment of chronic ulcerous skin lesions
GB0700911D0 (en) 2007-01-17 2007-02-28 First Water Ltd Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions
GB0715556D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
US20130200109A1 (en) 2012-02-06 2013-08-08 Frank Yang Foaming soap dispensers and methods
CN103622917B (zh) 2012-08-23 2017-12-29 尼奥克斯(文莱)控股有限公司 基于微囊化亚硝酸盐和酸化水凝胶的延时产生一氧化氮的系统和方法
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201309091D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
US20150072023A1 (en) * 2013-09-11 2015-03-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
CA2946828A1 (en) * 2014-03-14 2015-09-17 Nitric Solutions, Inc. Treating diseases using nitric oxide releasing solutions
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
WO2019175674A2 (en) * 2018-03-13 2019-09-19 Regev Gilly Nitric oxide releasing compositions
GB2599576B (en) * 2019-06-04 2023-09-13 Thirty Holdings Ltd Methods and compositions for generating nitric oxide and uses thereof
EP3980032A1 (en) * 2019-06-04 2022-04-13 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
WO2021023264A1 (zh) * 2019-08-06 2021-02-11 连云港金康和信药业有限公司 用于治疗非洲猪瘟的药物组合物及其用途
GB2610721B (en) * 2020-04-23 2024-07-31 Thirty Respiratory Ltd Compositions for treating and combatting tuberculosis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP2002538210A (ja) * 1999-03-09 2002-11-12 クイーン メアリー アンド ウェストフィールド カレッジ 皮膚虚血症を治療するための硝酸塩源及び酸性化剤を含む医薬組成物
JP2004508337A (ja) * 2000-09-08 2004-03-18 アバディーン　ユニヴァーシティ 薬剤耐性生物の治療
JP2005508957A (ja) * 2001-10-19 2005-04-07 バーツ　アンド　ザ　ロンドン　エヌエイチエス　トラスト 治療用組成物および用途
JP2009533396A (ja) * 2006-04-12 2009-09-17 バーツ アンド ザ ロンドン エヌエイチエス トラスト 治療用組成物及びその使用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 8, JPN6025010435, 2004, pages 223 - 226, ISSN: 0005743263 *
JOURNAL OF VIROLOGY, vol. 79, no. 3, JPN6025010436, 2005, pages 1966 - 1969, ISSN: 0005743264 *
SANOTIZE RESEARCH AND DEVELOPMENT CORP., [ONLINE], JPN6025010434, 22 April 2020 (2020-04-22), ISSN: 0005743262 *

Also Published As

Publication number Publication date
GB2610722B (en) 2024-07-31
GB2610722A (en) 2023-03-15
CN115884758A (zh) 2023-03-31
CA3180857A1 (en) 2021-10-28
WO2021214440A1 (en) 2021-10-28
EP4138795A1 (en) 2023-03-01
GB202217440D0 (en) 2023-01-04
BR112022021454A2 (pt) 2023-01-31
AU2021259360A1 (en) 2022-12-01
US20240016831A1 (en) 2024-01-18

Similar Documents

Publication Publication Date Title
JP7686578B2 (ja) 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
AU2020286677B2 (en) Methods and compositions for generating nitric oxide and uses thereof
US20240016831A1 (en) Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
CN115768413B (zh) 用于治疗及抗击结核病的方法和组合物
JP6824044B2 (ja) 真菌感染症の治療方法
JP2005508957A (ja) 治療用組成物および用途
WO2015058087A1 (en) Methods for treating lung infections and inflammation
AU2002334190A1 (en) Therapeutic composition and use
JP2021130715A (ja) 細気管支炎を有する乳幼児のための一酸化窒素吸入療法
US11786561B2 (en) Approach to sustained production and delivery of nitric oxide and s-nitrosothiols
JP2023513106A (ja) 一酸化窒素放出抗菌化合物、製剤、およびそれらに関連する方法
JP2025143385A (ja) クロファジミンの組成物、それを含む組合せ、その調製プロセス、それを含む使用及び処置方法
WO2023133588A1 (en) Methods for treating nontuberculous mycobacteria diseases
JP2026510419A (ja) 感染性または炎症性の疾患または障害の治療、改善または予防に使用するための一酸化窒素生成組成物、キット及び組合せ

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20221213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240408

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250311

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250318

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260115